Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer
NCT ID: NCT05755347
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2023-03-17
2024-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metastatic Breast Cancer-Specific Prognostic Tool
NCT05574478
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
NCT00037024
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
NCT07313306
Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study
NCT02682836
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
NCT04374825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
Subjects with metastatic breast carcinoma have been receiving treatment at the study center and responding to survey questionnaires.
General health survey questionnaires
Patient-reported outcome survey will be offered at baseline.
PROMIS Cancer Function Brief 3D profile questionnaires
Patient-reported outcome survey will be offered at baseline.
FACT-G questionnaires
Patient-reported outcome survey will be offered at baseline.
Godin Leisure-Time Exercise Questionnaire
Patient-reported outcome survey will be offered at baseline.
REAP-S questionnaires
Patient-reported outcome survey will be offered at baseline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General health survey questionnaires
Patient-reported outcome survey will be offered at baseline.
PROMIS Cancer Function Brief 3D profile questionnaires
Patient-reported outcome survey will be offered at baseline.
FACT-G questionnaires
Patient-reported outcome survey will be offered at baseline.
Godin Leisure-Time Exercise Questionnaire
Patient-reported outcome survey will be offered at baseline.
REAP-S questionnaires
Patient-reported outcome survey will be offered at baseline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
3. Age ≥ 18 years at the time of consent.
4. Recent diagnosis of new metastatic breast cancer at time of screening.
Exclusion Criteria
3. Dementia, altered mental status, or any psychiatric condition as determined by clinical or study team that would prohibit the understanding or rendering of informed consent.
4. Current incarceration.
5. Subject has already received treatment for metastatic breast cancer prior to screening.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sasha Knowlton, MD
Role: PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical trials at UNC Lineberger
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCCC2241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.